1. Global Electrosurgical Devices Market Revenue Share Analysis by Top 3 Companies
The top three companies in the electrosurgical devices market accounted for 57.99% of the market share, while other companies accounted for the remaining 42.01%. This shows that the electrosurgical devices market is highly concentrated, with the top three companies having a significant dominant position in the market, while other companies occupy a relatively small market share, showing the intensity of market competition and the market control of leading companies.
Figure Top 3 Market Share of Electrosurgical Devices Companies in 2022
2. Global Electrosurgical Devices Market Revenue Share Analysis by Major Players
Medtronic has maintained the largest market share from 2018 to 2023, although its share has slightly decreased from 32.79% in 2018 to 31.42% in 2023. Johnson & Johnson follows closely behind, with a slightly increased market share, from 16.68% in 2018 to 17.60% in 2023. The market shares of B. Braun Melsungen, Olympus Corporation, and CONMED are relatively stable and have not changed much. However, the market shares of companies such as ERBE Elektromedizin, Bovie Medical, KLS Martin, and Utah Medical Products are smaller and have not changed much. This shows that the electrosurgical equipment market is mainly dominated by a few large companies, among which Medtronic has the largest market share, while the market shares of other companies are relatively small, and the market concentration is high.
Table Major Players Production Value Share (2018-2023)
|
|
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
|
Medtronic |
32.79% |
32.00% |
32.56% |
31.74% |
31.44% |
31.42% |
|
Johnson & Johnson |
16.68% |
16.60% |
16.63% |
17.44% |
17.26% |
17.60% |
|
B. Braun Melsungen |
9.35% |
9.81% |
9.40% |
9.04% |
9.29% |
9.34% |
|
Olympus Corporation |
9.23% |
9.20% |
8.79% |
8.89% |
8.73% |
8.69% |
|
CONMED |
5.17% |
5.46% |
5.61% |
5.95% |
5.70% |
5.67% |
|
ERBE Elektromedizin |
3.33% |
3.41% |
3.30% |
3.23% |
3.21% |
3.15% |
|
Bovie Medical |
1.44% |
1.43% |
1.43% |
1.37% |
1.32% |
1.36% |
|
KLS Martin |
0.97% |
1.01% |
1.08% |
1.11% |
1.22% |
1.25% |
|
Utah Medical Products |
0.64% |
0.67% |
0.60% |
0.59% |
0.55% |
0.55% |
|
Others |
20.39% |
20.40% |
20.59% |
20.65% |
21.28% |
20.98% |
|
Total |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
3. Medtronic Electrosurgical Devices Market Analysis
3.1 Company Profiles
Medtronic is a medical technology company that designs, develops, manufactures and markets medical devices and solutions. It offers products for the treatment of heart valve disorders, heart failure, diseases of the coronary artery, aortic, peripheral vascular, venous renal and neurological diseases, spine and musculoskeletal disorders and diseases of the ear, nose, and throat. It also provides biologic solutions for the orthopedic and dental markets.
Table Company Profiles
|
Item |
Profile |
|
Company Name |
Medtronic |
|
Website |
www.medtronic.com |
|
Established Time |
1949 |
|
Headquarters |
USA |
|
Sales Region |
Worldwide |
|
Business Overview |
Medtronic is a medical technology company that designs, develops, manufactures and markets medical devices and solutions. It offers products for the treatment of heart valve disorders, heart failure, diseases of the coronary artery, aortic, peripheral vascular, venous renal and neurological diseases, spine and musculoskeletal disorders and diseases of the ear, nose, and throat. It also provides biologic solutions for the orthopedic and dental markets. |
|
Contact Information |
Tel: 800-633-8766 Add: 710 Medtronic Parkway, Minneapolis, Minnesota, 55432-5604, USA |
3.2 Electrosurgical Devices Product Introduction
Table Product Introduction
 |
|
ELECTROSURGICAL ELECTRODES Edge™ Coated Electrodes PRODUCT DETAILS Edge™ coated blades have been proven to provide performance beyond all other coated blade electrodes on the market. Edge™ needle electrodes are designed to deliver uncompromised cutting performance for fine dissection, no matter what type of tissue. |
3.3 Medtronic Electrosurgical Devices Market Performance
From 2018 to 2023, the production volume and market value of Medtronic’s electrosurgical equipment showed a trend of first decreasing and then increasing. In 2018, the production volume was 27,799 thousand units, the production value was 1,158.45 million US dollars, the unit price was 41.7 US dollars/unit, the gross profit was 29.1 US dollars/unit, and the gross profit margin was 69.90%. By 2020, the production volume dropped to 26,591 thousand units, the production value dropped to 1,068.3 million US dollars, the unit price was 40.2 US dollars/unit, the gross profit dropped to 27.6 US dollars/unit, and the gross profit margin was 68.77%. Subsequently, the production volume and production value increased year by year, reaching 31,576 thousand units in 2023, the production value increased to 1,302.68 million US dollars, the unit price was 41.3 US dollars/unit, the gross profit was 27.9 US dollars/unit, and the gross profit margin was 67.69%. This suggests that despite the decline in 2020, Medtronic has maintained a high gross margin overall, demonstrating its strong competitiveness in the electrosurgical equipment market and its ability to adapt to market changes.
Table Medtronic Production, Value, Price, Gross Margin 2018-2023
|
Medtronic |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
|
Production (K Units) |
27799 |
28693 |
26591 |
28393 |
29833 |
31576 |
|
Production Value (M USD) |
1158.45 |
1181.43 |
1068.30 |
1160.70 |
1247.88 |
1302.68 |
|
Price (USD/Unit) |
41.7 |
41.2 |
40.2 |
40.9 |
41.8 |
41.3 |
|
Gross (USD/Unit) |
29.1 |
28.5 |
27.6 |
27.9 |
28.3 |
27.9 |
|
Gross Margin |
69.90% |
69.20% |
68.77% |
68.33% |
67.72% |
67.69% |
4. Johnson & Johnson Electrosurgical Devices Market Analysis
4.1 Company Profiles
Johnson & Johnson researches, develops, manufactures, and sells pharmaceutical products, medical devices, and consumer products. The company provides pharmaceuticals for immune diseases, cancer, neurological disorders, infectious, cardiovascular, and metabolic diseases; consumer products in oral care, baby care, beauty, over the counter (OTC) medicines, women’s health and wound care categories; and medical devices for use in the cardiovascular, orthopedic, neurovascular care, general surgery and vision care fields. J&J distributes pharmaceutical and medical products to retailers, wholesalers, health care professionals and hospitals; and offers consumer products through retail outlets and distributors.
Table Company Profiles
|
Item |
Profile |
|
Company Name |
Johnson & Johnson |
|
Website |
www.jnjmedtech.com |
|
Established Time |
1886 |
|
Headquarters |
USA |
|
Sales Region |
Worldwide |
|
Business Overview |
Johnson & Johnson researches, develops, manufactures, and sells pharmaceutical products, medical devices, and consumer products. The company provides pharmaceuticals for immune diseases, cancer, neurological disorders, infectious, cardiovascular, and metabolic diseases; consumer products in oral care, baby care, beauty, over the counter (OTC) medicines, women’s health and wound care categories; and medical devices for use in the cardiovascular, orthopedic, neurovascular care, general surgery and vision care fields. J&J distributes pharmaceutical and medical products to retailers, wholesalers, health care professionals and hospitals; and offers consumer products through retail outlets and distributors. |
|
Contact Information |
Tel: +1 732 524-0400 Add: 1 Johnson And Johnson Plaza, New Brunswick, New Jersey, US 08933 |
4.2 Electrosurgical Devices Product Introduction
Table Product Introduction
 |
|
ENDOPATH™ Electrosurgery PROBE PLUS™ II System Irrigation, suction, and cautery in a single device. The ENDOPATH Electrosurgery PROBE PLUS II System is designed to increase surgical efficiency through reduced instrument exchanges1 by featuring interchangeable shafts that allow for multiple configurations. About this Device The ENDOPATH Electrosurgery Probe Plus II System is a 5mm multi-functional electrosurgery system that facilitates tissue dissection, coagulation, fluid evacuation and irrigation. It features interchangeable shafts that allow for multiple configurations, eliminating the need for additional devices. The device is available in two handles and seven electrode/shaft options. It is compatible with commonly used irrigation and suction devices, as well as monopoly electrosurgery units. Specialties Bariatric, Colorectal and General Procedures Laparoscopic procedures such as Cholecystectomy, Colectomy and Myomectomy Features & Benefits Multi-use The ENDOPATH™ Probe Plus II Multi-Functional Electrosurgery System facilitates tissue dissection, coagulation, fluid evacuation and irrigation. It’s designed to meet a wide variety of surgical needs. Optimized Ergonomics Enhanced pistol grip handle requires 73% less force to activate suction and irrigation.2 The system offers two handles and seven electrode/shaft options and is designed to facilitate one-handed use. Increased Surgical Efficiency The ENDOPATH™ Probe Plus II Multi-Functional Electrosurgery System features interchangeable shafts that allow multiple configurations to increase surgical efficiency through reduced instrument exchanges.1 It is compatible with commonly used irrigation and suction devices, as well as monopolar electrosurgery units. |
4.3 Johnson & Johnson Electrosurgical Devices Market Performance
In 2018, the production volume of Johnson & Johnson’s electrosurgical equipment was 19,139 thousand units, with a market value of US$589.18 million, a unit price of US$30.8/unit, a gross profit of US$20.9/unit, and a gross profit margin of 67.85%. By 2020, the production volume dropped to 17,507 thousand units, the market value dropped to US$545.67 million, the unit price was US$31.2/unit, the gross profit was US$21.0/unit, and the gross profit margin was 67.28%. Subsequently, the production volume and market value increased year by year. By 2023, the production volume reached 22,485 thousand units, the market value increased to US$729.72 million, the unit price was US$32.5/unit, the gross profit was US$21.2/unit, and the gross profit margin was 65.22%. This shows that despite the decline in 2020, Johnson & Johnson has maintained a relatively high gross profit margin overall.
Table Johnson & Johnson Production, Value, Price, Gross Margin 2018-2023
|
Johnson & Johnson |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
|
Production (K Units) |
19139 |
20206 |
17507 |
20242 |
21393 |
22485 |
|
Production Value (M USD) |
589.18 |
613.03 |
545.67 |
637.80 |
685.21 |
729.72 |
|
Price (USD/Unit) |
30.8 |
30.3 |
31.2 |
31.5 |
32.0 |
32.5 |
|
Gross (USD/Unit) |
20.9 |
20.5 |
21.0 |
20.9 |
21.2 |
21.2 |
|
Gross Margin |
67.85% |
67.61% |
67.28% |
66.27% |
66.10% |
65.22% |
